Blume backed Zoplar shuts shop in B2B healthcare exit

Blume Ventures-backed Zoplar shut its operations in February, just a month after it raised $3.4 mn in its Series A funding. The startup is now returning the capital raised in its Series A round to its investors. Zoplar decided to shutter its operations after Central Drugs Standard Control Organisation, earlier this year, said that imports of refurbished medical devices aren't allowed in country.